Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monique van der Kooij"'
Autor:
Daan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, Alfonsus J. M. Van den Eertwegh, John B. A. G. Haanen, Maureen Aarts, Franchette Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem B. De Groot, Geke A. P. Hospers, Melissa de Meza, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense, Astrid Van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Karijn Suijkerbuijk, Monique van der Kooij, Ellen Kapiteijn
Publikováno v:
Cancers, Vol 14, Iss 22, p 5694 (2022)
Nodular melanoma (NM) is associated with a higher locoregional and distant recurrence rate compared with superficial spreading melanoma (SSM); it is unknown whether the efficacy of systemic therapy is limited. Here, we compare the efficacy of immunot
Externí odkaz:
https://doaj.org/article/0a22e7df31c540e8ae0de87b42e4bf29
Autor:
Eystein S Husebye, Frederik Castinetti, Sherwin Criseno, Giuseppe Curigliano, Brigitte Decallonne, Maria Fleseriu, Claire E Higham, Isabella Lupi, Stavroula A Paschou, Miklos Toth, Monique van der Kooij, Olaf M Dekkers
Publikováno v:
European Journal of Endocrinology (EJE)
G1-G21
European Journal of Endocrinology
European Journal of Endocrinology, 2022, 187 (6), pp.G1-G21. ⟨10.1530/EJE-22-0689⟩
G1-G21
European Journal of Endocrinology
European Journal of Endocrinology, 2022, 187 (6), pp.G1-G21. ⟨10.1530/EJE-22-0689⟩
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with significant autoimmune endocrinopathies that pose both diagnostic and treatment challenges. The aim of this guideline is to provide clinicians with the be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445c006e3c368fd6e3149aeb486321eb
https://lirias.kuleuven.be/handle/20.500.12942/704726
https://lirias.kuleuven.be/handle/20.500.12942/704726